Sigmoido-ovarian fistula complicating ovarian carcinosarcoma: a case report

Author:

Siala Rakia1,Mseddi Mohamed A.1,Yaakoubi Chaima1,Kassar Alia Z.2,Guizeni Rami1,Slima Mohamed B.1

Affiliation:

1. General Surgery Department “B”, The Faculty of Medicine, The University of Tunis El Manar, La Rabta Hospital,

2. Anatamopathology Departement, The Faculty of Medicine, The University of Tunis El Manar, La Rabta Hospital, Tunis, Tunisia

Abstract

Introduction: Ovarian cancer is the leading cause of death from gynecological cancer. Ovarian carcinosarcomas represent a rare, aggressive entity with a poor prognosis. Spontaneous fistulization of ovarian cancer into the digestive tract is a rare phenomenon. Presentation of case: A 67-year-old woman with a significant history of cardiac rhythm disorders was consulted for abdominal pain. Examination revealed tachycardia and abdominal guarding. Biology pictured elevated inflammatory markers and low prothrombin time. The abdominal computed tomography scan suggested a perforated sigmoid tumor with a peri-colonic abscess and pneumoperitoneum. She was rushed to the operating theater. Upon exploration, it was an ovarian tumor fistulized to sigmoid with peritonitis. She had an en-bloc resection with a terminal stoma. Control radiological study revealed diffuse lymph node metastasis. She was scheduled for chemotherapy. Discussion: This complication worsens the prognosis. The fistulous communication in the digestive lumen leads to the overflow of its microbial deposit. The tumor, therefore, becomes superinfected and may result in pelvic peritonitis in case of secondary rupture. On the other hand, the patient is deprived of the benefit of undergoing neoadjuvant chemotherapy, which will decrease the chances of complete macroscopic cytoreduction. Through a literature review, we aim to shed light on this rare entity in order to clarify its pathophysiological consequences and make adequate therapeutic measures. Conclusion: Fistulization to the large intestine worsens the prognosis of ovarian carcinosarcomas. Surgery is mandatory and should comply with oncological requirements. Adjuvant therapy is mostly needed, although more studies should be conducted to delineate the regimen accurately.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference19 articles.

1. The SCARE 2023 guideline: updating consensus Surgical CAse REport (SCARE) guidelines;Sohrabi;Int J Surg,2023

2. Le cancer séreux de haut grade de l’ovaire en 2018: avancées et controverses;Mederos;REVMED,2018

3. Primary ovarian carcinosarcoma. Report Aceptado: enero 2014 of eight cases;Montalvo-Esquivel;Ginecol Obstet México,2014

4. Carcinosarcoma of the ovary: a single institution experience and review of the literature;Kanis;Eur J Gynaecol Oncol,2016

5. Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high grade serous carcinoma;Hollis;Br J Cancer,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3